Intrinsic Value of S&P & Nasdaq Contact Us

HeartBeam, Inc. BEAT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
49/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+316.7%

HeartBeam, Inc. (BEAT) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 9 Buy, 4 Hold.

The consensus price target is $5.00 (low: $4.00, high: $5.50), representing an upside of 316.7% from the current price $1.20.

Analysts estimate Earnings Per Share (EPS) of $-0.73 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.73 vs est $-0.73 (beat +0%). 2025: actual $-0.62 vs est $-0.61 (missed -1.2%). Analyst accuracy: 99%.

BEAT Stock — 12-Month Price Forecast

$5.00
▲ +316.67% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for HeartBeam, Inc., the average price target is $5.00, with a high forecast of $5.50, and a low forecast of $4.00.
The average price target represents a +316.67% change from the last price of $1.20.
Highest Price Target
$5.50
Average Price Target
$5.00
Lowest Price Target
$4.00

BEAT Analyst Ratings

Buy
13
Ratings
9 Buy
4 Hold
Based on 13 analysts giving stock ratings to HeartBeam, Inc. in the past 3 months
Rating breakdown
Buy
9 69%
Hold
4 31%
69%
Buy
9 analysts
31%
Hold
4 analysts
0%
Sell
0 analysts

EPS Estimates — BEAT

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.73 vs Est –$0.73 ▼ 0.0% off
2025 Actual –$0.62 vs Est –$0.61 ▼ 1.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — BEAT

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message